カテゴリ： GlobalData, アメリカ, 企業調査

Quest Diagnostics Inc (DGX)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Quest Diagnostics Inc (DGX) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7243
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：110
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology and diagnostic products. The company caters to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Madison, New Jersey, the US.

Quest Diagnostics Inc (DGX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Quest Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Quest Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Quest Diagnostics Inc, Medical Equipment, Deal Details 15
Asset Purchase 15
Quest Diagnostics to Acquire US Laboratory Services Business from Oxford Immunotec for USD170 Million 15
Quest Diagnostics Acquires Assets from California Laboratory Associates 17
Venture Financing 18
Clinical Genomics Technologies Raises USD26 Million in Venture Financing 18
Clinical Genomics Technologies Raises USD15 Million in Series A Financing Round 20
Partnerships 21
Vermillion Enters into Licensing Agreement with Quest Diagnostics 21
Clinical Genomics Enters into Licensing Agreement with CSIRO 22
Illumina Enters Into Licensing Agreement With Quest Diagnostics 23
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 24
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 25
Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 26
Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 27
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 28
Clinical Genomics Partners with Memorial Sloan Kettering Cancer Center 29
Biocept to Form Partnership with Quest Diagnostics Mexico 30
DermTech Enters into Agreement with Dermpath Diagnostics 31
Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 32
Genomic Vision Extends Agreement with Quest Diagnostics 33
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 34
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 35
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 36
PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 37
Quest Diagnostics Enters Into Technology Integration Agreement With Appian 38
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 39
Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 40
RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn’s Disease 41
Debt Offering 42
Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 42
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 44
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 46
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 48
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 50
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 51
Asset Transactions 52
Strand Life Sciences to Acquire India Diagnostics Business from Quest Diagnostics 52
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 53
Acquisition 55
Quest Diagnostics Acquires ReproSource 55
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 56
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 58
Quest Diagnostics May Sell itself 60
Spectra Labs To Acquire Shiel Medical Labs 61
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 62
Clinical Genomics Acquires Enterix From Quest Diagnostics 63
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 64
Access Genetics Acquires OralDNA Labs From Quest Diagnostics 66
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 67
Quest Diagnostics Inc – Key Competitors 68
Quest Diagnostics Inc – Key Employees 69
Quest Diagnostics Inc – Locations And Subsidiaries 70
Head Office 70
Other Locations & Subsidiaries 70
Joint Venture 73
Recent Developments 74
Strategy And Business Planning 74
May 24, 2018: UnitedHealthcare Establishes Long-Term Strategic Partnership with Quest Diagnostics 74
Jan 26, 2017: Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services 75
Financial Announcements 76
Jul 24, 2018: Quest Diagnostics Reports Second Quarter 2018 Financial Results 76
Apr 19, 2018: Quest Diagnostics Reports First Quarter 2018 Financial Results 77
Feb 01, 2018: Quest Diagnostics Reports Fourth Quarter And Full Year 2017 Financial Results; Provides Guidance For Full Year 2018; Increases Dividend 11% To $0.50 Per Quarter 78
Oct 19, 2017: Quest Diagnostics Reports Third Quarter 2017 Financial Results 80
Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 81
Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook 82
Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 83
Corporate Communications 84
Aug 16, 2018: Quest Diagnostics earns gold status in American Heart Association’s workplace health achievement index 84
May 17, 2018: Quest Diagnostics adds Helen Torley to Board of Directors 85
May 07, 2018: Forbes Names Quest Diagnostics One of America’s Best Large Employers 86
Jan 30, 2018: ChartMaxx from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’ 87
Legal and Regulatory 88
Dec 11, 2017: Quest Diagnostics supports suit against HHS charging that CMS ignored congressional intent in implementing new clinical lab payment system 88
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 89
Government and Public Interest 90
Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests 90
Product News 91
Jun 23, 2018: One Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics Study 91
Jul 19, 2017: Quest Diagnostics Launches QHerit, a Pan-Ethnic Genetic Screening Panel Aligned with New Medical Guidelines 92
Feb 16, 2017: Quest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care 93
Other Significant Developments 94
Oct 10, 2018: Quest Diagnostics Launches the Global Diagnostics Network (GDN) to Improve Healthcare by Increasing Access to Diagnostic Insights Around the World 94
Sep 26, 2018: Quest Diagnostics partners With RMC Health System to deliver high-value innovative laboratory services 95
Jul 30, 2018: New quest diagnostics data shows lyme disease prevalence increasing and is now present in new U.S. states 96
Jul 17, 2018: Quest Diagnostics: New Study Reveals Stalled Progress Toward Value-Based Care 98
Jul 09, 2018: LabFinder.com Adds Quest Diagnostics to Roster of Subscribers 100
May 23, 2018: Physicians Lack the Time and Tools to Discover Hidden Risks in Patients with Chronic Conditions, Finds Study from Quest Diagnostics 101
Sep 27, 2017: Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes 103
Sep 26, 2017: Rx Savings Solutions Helps Quest Diagnostics’ Health Plan Members Save Money On Prescription Drugs 104
Sep 22, 2017: Quest Diagnostics Responds to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests 105
Sep 07, 2017: Quest Diagnostics Moves to Convenient Nonfasting Cholesterol Testing with Improved Method for Assessing Heart Disease Risk and Aiding Treatment Decisions 106
Aug 30, 2017: MDI Solutions selected to provide Cloverleaf Secure Courier implementation and training services 108
Jan 18, 2017: Quest Diagnostics Launches Nation’s First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy 109
Appendix 110
Methodology 110
About GlobalData 110
Contact Us 110
Disclaimer 110

List of Tables
Quest Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Quest Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Quest Diagnostics Inc, Deals By Market, 2012 to YTD 2018 11
Quest Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Quest Diagnostics to Acquire US Laboratory Services Business from Oxford Immunotec for USD170 Million 15
Quest Diagnostics Acquires Assets from California Laboratory Associates 17
Clinical Genomics Technologies Raises USD26 Million in Venture Financing 18
Clinical Genomics Technologies Raises USD15 Million in Series A Financing Round 20
Vermillion Enters into Licensing Agreement with Quest Diagnostics 21
Clinical Genomics Enters into Licensing Agreement with CSIRO 22
Illumina Enters Into Licensing Agreement With Quest Diagnostics 23
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 24
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test 25
Matrix-Bio Enters Into Licensing Agreement With Quest Diagnostics For Metabolomic Biomarkers 26
Clinical Genomics Enters Into Licensing Agreement With Quest Diagnostics For Colon Cancer Markers 27
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 28
Clinical Genomics Partners with Memorial Sloan Kettering Cancer Center 29
Biocept to Form Partnership with Quest Diagnostics Mexico 30
DermTech Enters into Agreement with Dermpath Diagnostics 31
Commonwealth Labs Enters into Agreement with Quest Diagnostics for IBSchek 32
Genomic Vision Extends Agreement with Quest Diagnostics 33
Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 34
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 35
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 36
PrimeraDx Enters Into Co-Development Agreement With Quest Diagnostics 37
Quest Diagnostics Enters Into Technology Integration Agreement With Appian 38
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 39
Apenimed Enters Into Technology Integration Agreement With Quest Diagnostics 40
RedHill Biopharma Enters Into Co-Development Agreement With Quest Diagnostics To Develop MAP Test For Crohn's Disease 41
Quest Diagnostics Raises USD500 Million in Public Offering of 3.45% Senior Notes due 2026 42
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 44
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 46
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 48
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 50
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 51
Strand Life Sciences to Acquire India Diagnostics Business from Quest Diagnostics 52
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 53
Quest Diagnostics Acquires ReproSource 55
Quest Diagnostics Acquires Shiel Medical from Fresenius Medical 56
Quest Diagnostics Acquires Cleveland HeartLab from Cleveland Clinic and Advantage Capital 58
Quest Diagnostics May Sell itself 60
Spectra Labs To Acquire Shiel Medical Labs 61
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 62
Clinical Genomics Acquires Enterix From Quest Diagnostics 63
Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For US$300 Million 64
Access Genetics Acquires OralDNA Labs From Quest Diagnostics 66
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 67
Quest Diagnostics Inc, Key Competitors 68
Quest Diagnostics Inc, Key Employees 69
Quest Diagnostics Inc, Subsidiaries 70
Quest Diagnostics Inc, Joint Venture 73

List of Figures
Quest Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Quest Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Quest Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Quest Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Quest Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

★海外企業調査レポート[Quest Diagnostics Inc (DGX)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Camellia PLC (CAM)：企業の財務・戦略的SWOT分析
    Summary Camellia Plc (Camellia) is a provider of business processing services. The company operates business through agriculture, food service, engineering and investment sectors. Camellia’s agriculture business division offers products such as rubber, maize, citrus, soya and barley, wine, pineapple …
  • LPL Financial Holdings Inc (LPLA)：企業の財務・戦略的SWOT分析
    LPL Financial Holdings Inc (LPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • nLife Therapeutics SL：製薬・医療：M&Aディール及び事業提携情報
    Summary nLife Therapeutics SL (nLife Therapeutics) is a biopharmaceutical company that discovers and develops cell specific oligonucleotides as therapeutic agents for the treatment of central nervous system and neuromuscular disorders. The company’s lead candidate includes NLF-PD-1233, an oligonucle …
  • Exelixis Inc (EXEL)-製薬・医療分野：企業M&A・提携分析
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabometyx (c …
  • Crown Point Energy Inc (CWV)：石油・ガス：M&Aディール及び事業提携情報
    Summary Crown Point Energy Inc (Crown Point), formerly Crown Point Ventures is an oil and gas company that offers oil and gas development and exploration services. The company acquires and produces crude oil and natural gas deposits. It holds interests in Cerro de Los Leones exploration concessions …
  • CureMeta LLC-製薬・医療分野：企業M&A・提携分析
    Summary CureMeta LLC (CureMeta) is a biotechnology company that concentrates on the development of immunology therapeutics for cancers. The company advances novel antibody drug conjugates targeting pluripotent stem cells. Its pipeline product comprises Bstrongximab-ADC. CureMeta develops the antibod …
  • Kurita Water Industries Ltd：企業の戦略・SWOT・財務情報
    Kurita Water Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Kurita Water Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fortitech Inc.：戦略・SWOT・企業財務分析
    Fortitech Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortitech Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Clinicient Inc-医療機器分野：企業M&A・提携分析
    Summary Clinicient Inc (Clinicient) is a healthcare technology company that offers EMR management and therapy practice solutions. The company offers insight platform software that offers single system created exclusively for outpatient rehab that populates data across both the clinical and financial …
  • EnviTec Biogas AG (ETG)：企業の財務・戦略的SWOT分析
    EnviTec Biogas AG (ETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Sirius XM Holdings Inc.：企業の戦略・SWOT・財務情報
    Sirius XM Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sirius XM Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PizzaExpress Limited：企業の戦略・SWOT・財務情報
    PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report Summary PizzaExpress Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • BioMark Diagnostics Inc：医療機器：M&Aディール及び事業提携情報
    Summary BioMark Diagnostics Inc (BioMark Diagnostics) is an oncology-focused medical equipment company that owns and develops multiple intellectual properties in detection and quantitation of metabolites. The company’s advanced near-to- market diagnostic technologies designed to improve patient outc …
  • Metropolitan Bank and Trust Company：企業の戦略・SWOT・財務分析
    Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report Summary Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Polpharma SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • Jardine Engineering Corporation, Limited
    Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Southern Research Institute-製薬・医療分野：企業M&A・提携分析
    Summary Southern Research Institute (Southern Research) is a contract research organization which conducts research in the areas of advanced engineering, preclinical drug development, drug discovery and environmental protection. Its life science services include preclinical drug development, basic r …
  • Yahoo Japan Corporation (4689)：企業の財務・戦略的SWOT分析
    Yahoo Japan Corporation (4689) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Gr. Sarantis S.A. (SAR)：企業の財務・戦略的SWOT分析
    Gr. Sarantis S.A. (SAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Oando Plc (OANDO)：石油・ガス：M&Aディール及び事業提携情報
    Summary Oando Plc (Oando) is a provider of integrated energy solutions to the oil and gas industry. Through its subsidiaries, the company explores for and produces oil and gas through the acquisition of rights in oil blocks on the Nigerian continental shelf and deep offshore. It has producing, devel …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆